Hi, what are you looking for?
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International...
In the 11th Oct 2015 edition of Israel’s good news, the highlights include: · An Israeli charity’s bone marrow registry saved 25 lives...
Gamida Cell develops cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Cancer therapy project wins International award; John Lewis uses Israeli tech for virtual showroom, and more good news from Israel.
In the 20th Sep 2015 edition of Israel’s good news, the highlights include: · South Africa has chosen an Israeli system to screen...
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April
In the 13th Sep 2015 edition of Israel’s good news, the highlights include: · An Israeli brain cancer treatment device is shown saving...
Trying to fend off a hostile takeover attempt by Mylan’s $27 billion bid, Perrigo Chairman, President and CEO Joseph Papa sent a letter...
Mylan N.V. (NASDAQ: MYL) shareholders have approved Mylan’s proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE). The transaction received the approval of two-thirds of...
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"